C07C 313/26
Compounds containing any of the groups [image cpc-sch-c07c-0978.gif], x being a hetero
Official title: Compounds containing any of the groups [IMAGE cpc-sch-C07C-0978.gif], X being a hetero atom, Y being any atom
C07C313/26 (Compounds containing any of the groups [image cpc-sch-c07c-0978.gif], x being a hetero) appears on 52 US grants and 7 published applications in this corpus.
Search patents in C07C- Granted patents
- 52
- Published applications
- 7
- Assignees
- 25
- Inventors
- 114
- Latest grant
- 21 Jul 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 5 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Inhibitors of creatine transport and uses thereof21 Jul 2020US 10,717,704 B2Rgenix, Inc.
- Inhibitors of creatine transport and uses thereof4 Jun 2019US 10,308,597 B2Rgenix, Inc.
- Treatment of muscle disease characterized by insulin resistance31 Mar 2015US 8,993,633 B2Fate Therapeutics, (Canada) Inc.
- Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumor agents19 Oct 2010US 7,816,386 B2Sigma-Tau Industrie Farmaceutiche Riunite S. P.A.,
- Method of treating a disease condition caused or exacerbated by an HPV28 Mar 2006US 7,019,000 B1Institute of Molecular and Cell Biology
- Compound for capping layer and organic light emitting device including same13 Jun 2024US 2024/0190810 A1Dongjin Semichem Co., Ltd.
- Compound for capping layer and organic light emitting device including same16 May 2024US 2024/0164138 A1Dongjin Semichem Co., Ltd.
- Inhibitors of creatine transport and uses thereof17 Oct 2019US 2019/0315680 A1Rgenix, Inc.
- Inhibitors of creatine transport and uses thereof23 Feb 2017US 2017/0050924 A1Rgenix, Inc.
- Treatment of muscle disease characterized by insulin resistance15 Mar 2012US 2012/0065176 A1Fate Therapeutics, (Canada) Inc.
Most cited
By later US patents
- GnRH analogs44US 5,296,468 AThe Salk Institute for Biological Studies · 1994
- Amino acids useful in making GnRH analogs33US 5,352,796 AThe Salk Institute for Biological Studies · 1994
- GnRH analogs28US 5,169,932 AThe Salk Institute for Biological Studies · 1992
- Insecticidal compounds and compositions21US 4,987,141 AImperial Chemical Industries PLC · 1991
- Carbamates and crop protection agents containing them21US 5,824,705 ABASF SE · 1998